News and Announcements
Prescient Chief Scientific Officer Named Among Top 20 Translational Researchers by Nature
- Published September 02, 2015 10:36AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
1st September 2015, ASX Announcement
Prescient Therapeutics (ASX:PTX), a clinical stage oncology company, is pleased to announce that its Chief Scientific Officer and co-investor of PTX’s technologies, Professor Said Sebti, has been named as one of the Top 20 Translational Researchers in the world by the prestigious science publisher Nature Publishing Group.
Professor Sebti has been ranked alongside Nobel laureate Dr David Baltimore on the internationally regarded list, which is complied by patent analytics firm IP Checkups following examination of 2014’s most active scientists for patenting.
Scientists are included on the list following examination of each researcher’s most-cited patent from the previous five years and their ‘H index’, which is a score based on the impact of published work.
As well as overseeing Prescient’s oncology programs, Professor Sebti is the Manuel and Adeline Garcia Endowed Professor and Chair, Department for Drug Discovery, at the Moffitt Cancer Center in Florida; a National Cancer Institute-designated comprehensive cancer center, and one of the largest cancer centers in the US.
To read the full announcement, please click here.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
